Intuitive Surgical (NASDAQ:ISRG – Free Report) had its price objective lowered by Truist Financial from $666.00 to $605.00 in a report published on Monday, Marketbeat.com reports. The brokerage currently has a buy rating on the medical equipment provider’s stock.
A number of other analysts have also issued reports on the stock. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Barclays raised their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Leerink Partners raised their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Jefferies Financial Group raised their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $611.86.
View Our Latest Research Report on ISRG
Intuitive Surgical Price Performance
Insider Transactions at Intuitive Surgical
In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.90% of the company’s stock.
Institutional Investors Weigh In On Intuitive Surgical
Institutional investors have recently bought and sold shares of the business. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical during the fourth quarter worth $449,000. Seilern Investment Management Ltd bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $82,517,000. Sycomore Asset Management lifted its holdings in shares of Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares during the period. Exome Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after acquiring an additional 525 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- What is a support level?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Insider Buying Explained: What Investors Need to Know
- Alphabet’s Officially In A Bear Market—Time To Buy?
- 3 Best Fintech Stocks for a Portfolio Boost
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.